Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by robertshawon Jul 29, 2017 6:08pm

127 Views

Post# 26525644

RE:RE:RE:TLT clinical trail conundrum

ProOrbite wrote:
Wanted to add this from my previous post to the last but clicked post to soon.
So I wil redo one point with another aspect to it. Sorry...But the new point is at the end!

PhilDavis wrote:
"TLT demonstrated absence of cancer recurrence in 2 out of 3 patients so far. Third is yet to be officially confirmed. Although I personally expect nothing short of cancer-free for him too, scientific, medical and broader financial community do not share a view of an enthusiastic TLT stockholder. They rely only on statistics (factual data)."

SO WRONG!!
As quoted from the news release! The three patients have NO RECURRENCE OF NMIBC so to me thats Cancer free! That is a fact and officially confirmed at the three month point!!

"The first three (3) patients have demonstrated no recurrence of NMIBC lesions at the ninety (90) day cystoscopy analysis." Not 2 but 3 are CANCER FREE! see news release below to reread!

https://theralase.com/pressrelease/theralase-achieves-exploratory-endpoint-of-efficacy-for-anti-cancer-technology/

NEW POINT HERE BELOW:

With many other treatments for cancer used today there is a mutogenic factor in it. You can obliterate that cancer cell but that proceedure can be mutogenic! Meaning that the seeds of new cancer can and may appear and spread in other places of the body from what I have read and understand!

Since the 3 have no recurrence of NMIBC at the 90 day cystoscopy the fear with other treatments would be the mutogenic factor to recreate cancer else where within the body!

BUT!!!!!! PDC are not mutogenic! RW emphasises the important point of this in the video below.
This at @ 18.30 of the video..

NOUN
mutagens (plural noun)
an agent, such as radiation or a chemical substance, that causes genetic mutation

So RW is saying that this will not cause cancer to spread after treatment which initself is astounding for me anyways.

So can yousay increased efficacy of this treatment going forward with PDC! You betcha!
Will the 180 day cystoscopy analysis have the higest probability for success to reveal tht they are still NMIBC lesions free? I think so...

https://www.youtube.com/watch?v=3Zz7CkBRDN8
Read more at https://www.stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=26521298#mPr5SbHdqOTmMu7m.99

So good luck to all.

'Cause I'm T.L.D., I'm dynamite        (TLD-1433)
(T.L.D.) and I'll win the fight              (Against cancer)
(T.L.D.) I'm a power load                  (Cancer Koolaid)
(T.L.D.) watch me explode                (Light activated)

(Oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi, oi)